The main adverse events of ALK TKIs are cardiovascular effects: QT prolongation (Camidge et al., 2019), bradycardia (Camidge et al., 2018), thrombotic events (Hou et al., 2019), or hypertension (Camidge et al., 2018). The gene discussed is ALK; the disease is Hypertension.